Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    November 2017
  1. BIGGS MA, Taylor D, Upadhyay UD
    Role of Insurance Coverage in Contraceptive Use After Abortion.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002361.
    PubMed     Text format     Abstract available



  2. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:e251-e269.
    PubMed     Text format     Abstract available



  3. Practice Bulletin No. 186 Summary: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:1173-1175.
    PubMed     Text format     Abstract available


    October 2017
  4. MONIZ MH, Gavin LE, Dalton VK
    Performance Measures for Contraceptive Care: A New Tool to Enhance Access to Contraception.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002314.
    PubMed     Text format     Abstract available


  5. MENKE MN, King WC, White GE, Gosman GG, et al
    Contraception and Conception After Bariatric Surgery.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002323.
    PubMed     Text format     Abstract available


    September 2017
  6. CHEN MJ, Hou MY, Hsia JK, Cansino CD, et al
    Long-Acting Reversible Contraception Initiation With a 2- to 3-Week Compared With a 6-Week Postpartum Visit.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002246.
    PubMed     Text format     Abstract available


  7. MONIZ MH, Spector-Bagdady K, Heisler M, Harris LH, et al
    Inpatient Postpartum Long-Acting Reversible Contraception: Care That Promotes Reproductive Justice.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002262.
    PubMed     Text format     Abstract available


    August 2017
  8. ISEYEMI A, Zhao Q, McNicholas C, Peipert JF, et al
    Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE Project.
    Obstet Gynecol. 2017 Aug 4. doi: 10.1097/AOG.0000000000002189.
    PubMed     Text format     Abstract available



  9. Committee Opinion No. 710: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:e74-e80.
    PubMed     Text format     Abstract available



  10. Committee Opinion No. 710 Summary: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:486-487.
    PubMed     Text format     Abstract available


    July 2017
  11. POTTER JE, Coleman-Minahan K, White K, Powers DA, et al
    Contraception After Delivery Among Publicly Insured Women in Texas: Use Compared With Preference.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002136.
    PubMed     Text format     Abstract available



  12. Committee Opinion No 707: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:e48-e52.
    PubMed     Text format     Abstract available



  13. Committee Opinion No. 707 Summary: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:251-252.
    PubMed     Text format     Abstract available


    June 2017
  14. KRASHIN JW, Stuart GS, Garrett J, Spector H, et al
    Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002070.
    PubMed     Text format     Abstract available


  15. CARMO LSMP, Braga GC, Ferriani RA, Quintana SM, et al
    Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002092.
    PubMed     Text format     Abstract available


  16. MCHUGH KW, Tucker Edmonds B, Ferries-Rowe E, Haas DM, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2017;129:1136-1137.
    PubMed     Text format    


    May 2017
  17. MONIZ MH, Chang T, Heisler M, Admon L, et al
    Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
    Obstet Gynecol. 2017 May 5. doi: 10.1097/AOG.0000000000001970.
    PubMed     Text format     Abstract available



  18. Committee Opinion No 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:e142-e149.
    PubMed     Text format     Abstract available



  19. Committee Opinion No. 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:965-966.
    PubMed     Text format     Abstract available


  20. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception.
    Obstet Gynecol. 2017;129:783-785.
    PubMed     Text format    


    April 2017
  21. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception: Speak Up Against the Global Gag Rule.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000002028.
    PubMed     Text format    


  22. ERICKSON AK, Nelson DA, Shaw JG, Loftus PD, et al
    Long-Acting Reversible Contraceptive Placement Among Active-Duty U.S. Army Servicewomen.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000001971.
    PubMed     Text format     Abstract available



  23. Committee Opinion No. 695: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:e109-e116.
    PubMed     Text format     Abstract available



  24. Committee Opinion No 695 Summary: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:775-776.
    PubMed     Text format     Abstract available


    March 2017
  25. DARNEY BG, Aiken AR, Kung S
    Access to Contraception in the Context of Zika: Health System Challenges and Responses.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001914.
    PubMed     Text format     Abstract available


  26. GOYAL V, Canfield C, Aiken AR, Dermish A, et al
    Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001926.
    PubMed     Text format     Abstract available


    February 2017
  27. YANG YT, Sawicki NN
    Pharmacies' Duty to Dispense Emergency Contraception: A Discussion of Religious Liberty.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001894.
    PubMed     Text format     Abstract available


    January 2017
  28. WALTER JR, Ghobadi CW, Hayman E, Xu S, et al
    Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.
    Obstet Gynecol. 2017;129:10-19.
    PubMed     Text format     Abstract available


  29. SCHNATZ PF, Jiang X, Aragaki AK, Nudy M, et al
    Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
    Obstet Gynecol. 2017;129:121-129.
    PubMed     Text format     Abstract available



  30. Clinical Updates in Women's Health Care Summary: Liver Disease: Reproductive Considerations.
    Obstet Gynecol. 2017;129:236.
    PubMed     Text format     Abstract available


    December 2016
  31. HOFLER LG, Cordes S, Cwiak CA, Goedken P, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  32. HIGGINS JA, Sanders JN, Palta M, Turok DK, et al
    Women's Sexual Function, Satisfaction, and Perceptions After Starting Long-Acting Reversible Contraceptives.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  33. SCOCCIA B
    What Is New in Polycystic Ovary Syndrome?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  34. ABBAS DF, Blum J, Ngoc NT, Nga NT, et al
    Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  35. RAYMOND EG, Weaver MA, Louie KS, Tan YL, et al
    Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available



  36. Committee Opinion No 672: Clinical Challenges of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2016;128:e69-77.
    PubMed     Text format     Abstract available



  37. Committee Opinion No 672 Summary Clinical Challenges of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2016;128:674-5.
    PubMed     Text format     Abstract available


    August 2016

  38. Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception.
    Obstet Gynecol. 2016;128:e32-7.
    PubMed     Text format     Abstract available



  39. Committee Opinion No. 670 Summary: Immediate Postpartum Long-Acting Reversible Contraception.
    Obstet Gynecol. 2016;128:422-3.
    PubMed     Text format     Abstract available



  40. Adjunctive Social Media for More Effective Contraceptive Counseling: A Randomized Controlled Trial: Correction.
    Obstet Gynecol. 2016;128:411.
    PubMed     Text format    



  41. Committee Opinion No. 668: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:e20-5.
    PubMed     Text format     Abstract available



  42. Committee Opinion No. 668 Summary: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:418-9.
    PubMed     Text format     Abstract available


    June 2016
  43. RODRIGUEZ MI, Anderson L, Edelman AB
    Prescription of Hormonal Contraception by Pharmacists in Oregon: Implementation of House Bill 2879.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  44. STUART GS
    What Is New in Long-Acting Reversible Contraception?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  45. MOGLIA ML, Nguyen HV, Chyjek K, Chen KT, et al
    Evaluation of Smartphone Menstrual Cycle Tracking Applications Using an Adapted APPLICATIONS Scoring System.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  46. SIMMONS K, Edelman A, Fu R, Jensen J, et al
    A Short Course of Tamoxifen Reduces Unscheduled Bleeding in Etonogestrel Contraceptive Implant Users [24].
    Obstet Gynecol. 2016;127 Suppl 1:9S.
    PubMed     Text format     Abstract available


    February 2016
  47. GALLO MF, Legardy-Williams J, Hylton-Kong T, Rattray C, et al
    Association of Progestin Contraceptive Implant and Weight Gain.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  48. BOOZALIS A, Tutlam NT, Chrisman Robbins C, Peipert JF, et al
    Sexual Desire and Hormonal Contraception.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  49. POTTER JE, Hubert C, Stevenson AJ, Hopkins K, et al
    Barriers to Postpartum Contraception in Texas and Pregnancy Within 2 Years of Delivery.
    Obstet Gynecol. 2016;127:289-96.
    PubMed     Text format     Abstract available


  50. RAYMOND EG, Weaver MA, Tan YL, Louie KS, et al
    Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016;127:306-12.
    PubMed     Text format     Abstract available


    December 2015
  51. D'ALTON ME
    Every Woman, Every Time: Opportunity for Improvement.
    Obstet Gynecol. 2015;126:1133-5.
    PubMed     Text format    


    November 2015
  52. CHAMPALOUX SW, Tepper NK, Curtis KM, Zapata LB, et al
    Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  53. LEMAIRE WJ
    Feminism and the Moral Imperative for Contraception.
    Obstet Gynecol. 2015;126:1108.
    PubMed     Text format    


  54. ESPEY E
    In Reply.
    Obstet Gynecol. 2015;126:1108.
    PubMed     Text format    


  55. CHEN MJ, Creinin MD
    In Reply.
    Obstet Gynecol. 2015;126:1107-8.
    PubMed     Text format    


  56. BLUMENTHAL PD
    Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Obstet Gynecol. 2015;126:1107.
    PubMed     Text format    



  57. ACOG Committee Opinion No. 646: Ethical Considerations for Including Women as Research Participants.
    Obstet Gynecol. 2015;126:e100-7.
    PubMed     Text format     Abstract available


  58. CHEN MJ, Creinin MD
    Removal of a Nonpalpable Etonogestrel Implant With Preprocedure Ultrasonography and Modified Vasectomy Clamp.
    Obstet Gynecol. 2015;126:935-8.
    PubMed     Text format     Abstract available


  59. GILLIAM ML
    Beyond Coercion: Let Us Grapple With Bias.
    Obstet Gynecol. 2015;126:915-6.
    PubMed     Text format    


    October 2015
  60. KAKAIRE O, Byamugisha JK, Tumwesigye NM, Gemzell-Danielsson K, et al
    Intrauterine Contraception Among Women Living With Human Immunodeficiency Virus: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  61. KAVANAUGH ML, Jerman J, Finer LB
    Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009-2012.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available



  62. Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy.
    Obstet Gynecol. 2015;126:e44-8.
    PubMed     Text format     Abstract available



  63. Committee Opinion No. 642 Summary: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy.
    Obstet Gynecol. 2015;126:912.
    PubMed     Text format     Abstract available


    September 2015
  64. CHANG K, Merideth MA, Stratton P
    Hormone Use for Therapeutic Amenorrhea and Contraception During Hematopoietic Cell Transplantation.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  65. ABRAHAM M, Zhao Q, Peipert JF
    Young Age, Nulliparity, and Continuation of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available



  66. Practice Bulletin No. 152: Emergency Contraception.
    Obstet Gynecol. 2015;126:e1-e11.
    PubMed     Text format     Abstract available



  67. Practice Bulletin Summary No. 152: Emergency Contraception.
    Obstet Gynecol. 2015;126:685-6.
    PubMed     Text format     Abstract available


    August 2015
  68. ESPEY E
    Feminism and the Moral Imperative for Contraception.
    Obstet Gynecol. 2015;126:396-400.
    PubMed     Text format     Abstract available


  69. LINDLEY KJ, Madden T, Cahill AG, Ludbrook PA, et al
    Contraceptive Use and Unintended Pregnancy in Women With Congenital Heart Disease.
    Obstet Gynecol. 2015;126:363-9.
    PubMed     Text format     Abstract available


  70. BIGGS MA, Harper CC, Brindis CD
    California Family Planning Health Care Providers' Challenges to Same-Day Long-Acting Reversible Contraception Provision.
    Obstet Gynecol. 2015;126:338-45.
    PubMed     Text format     Abstract available


    July 2015
  71. GOLDBERG AB, Fortin JA, Drey EA, Dean G, et al
    Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  72. GUIAHI M, McBride M, Sheeder J, Teal S, et al
    Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  73. DOMINICK SA, McLean MR, Whitcomb BW, Gorman JR, et al
    Contraceptive Practices Among Female Cancer Survivors of Reproductive Age.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  74. HOPKINS MR, Laughlin-Tommaso SK, Wall DJ, Breitkopf DM, et al
    Hysterosalpingography After Radiofrequency Endometrial Ablation and Hysteroscopic Sterilization as a Concomitant Procedure.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  75. DIVASTA AD, Feldman HA, Sadler Gallagher J, Stokes NA, et al
    Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  76. GARIEPY AM, Duffy JY, Xu X
    Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
    Obstet Gynecol. 2015;126:47-55.
    PubMed     Text format     Abstract available


  77. CHEN MJ, Creinin MD
    Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Obstet Gynecol. 2015;126:12-21.
    PubMed     Text format     Abstract available


  78. DALTON VK, Wallett S
    The Evolution of Medication Abortion Care: Using Science to Achieve Quality.
    Obstet Gynecol. 2015;126:3-4.
    PubMed     Text format    


    June 2015
  79. WHITE K, Teal SB, Potter JE
    Contraception after delivery and short interpregnancy intervals among women in the United States.
    Obstet Gynecol. 2015;125:1471-7.
    PubMed     Text format     Abstract available


    May 2015
  80. LEKOVICH JP, Amrane S, Pangasa M, Pereira N, et al
    Comparison of human papillomavirus infection and cervical cytology in women using copper-containing and levonorgestrel-containing intrauterine devices.
    Obstet Gynecol. 2015;125:1101-5.
    PubMed     Text format     Abstract available


    March 2015
  81. MCNICHOLAS C, Maddipati R, Zhao Q, Swor E, et al
    Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the u.s. Food and drug administration-approved duration.
    Obstet Gynecol. 2015;125:599-604.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: